|Table of Contents|

Analysis of serum differential proteins in patients with bone metastases and non-bone metastases in lung adenocarcinoma based on 4D-DIA proteomics

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 10
Page:
1824-1831
Research Field:
Publishing date:

Info

Title:
Analysis of serum differential proteins in patients with bone metastases and non-bone metastases in lung adenocarcinoma based on 4D-DIA proteomics
Author(s):
LI Maochen12LAI Xueting2ZHANG Hongxia12WANG Bu2ZHANG Zhihua2ZHANG Xiulong2
1.Graduate School of Hebei North University,Hebei Zhangjiakou 075000,China;2.The First Affiliated Hospital of Hebei North University,Hebei Zhangjiakou 075000,China.
Keywords:
lung adenocarcinomabone metastasesproteomicsnovel protein markers
PACS:
R734.2
DOI:
10.3969/j.issn.1672-4992.2024.10.011
Abstract:
Objective:To find the differential proteins between lung adenocarcinoma bone metastasis and adenocarcinoma non-bone metastasis based on deep blood 4D-DIA proteomic analysis,so as to provide a basis for diagnosis and treatment of lung adenocarcinoma bone metastasis.Methods:Serum proteomics analysis was performed in 6 patients with lung adenocarcinoma non-bone metastases (LUADNBM) and 6 patients with lung adenocarcinoma bone metastasis (LUADBM) using 4D-DIA proteomics.The expression fold (fold change,FC) was >1.5-fold (up-regulated by more than 1.5-fold or down-regulated by less than 0.67-fold) and P value<0.05 (T-test or other) was used as the standard to obtain the number of up-regulated and down-regulated proteins between the comparison groups.Gene set enrichment analysis (GSEA) was performed on quantifiable proteins between different comparison groups.Principal component analysis (PCA),gene ontology (GO) analysis and KEGG (Kyoto encyclopedia of genes and genomes) pathway database were performed on the String website and R language.Results:A total of 2 585 quantifiable proteins were found between the LUADNBM group and the LUADBM group,including 18 differential proteins.The results of GSEA showed that the quantified protein was mainly enriched in the eukaryotic translation extension stage and the main translation mechanism pathway of SARS-CoV-2 (P<0.05).The results of PCA showed that the differential protein could clearly distinguish LUADNBM from LUADBM patients.The results of GO analysis showed that the differential proteins were mainly enriched in the lumen of the Golgi canal and extracellular matrix,and played an important role in the biosynthesis and metabolism of cutaneous sulfate proteoglycans and the catabolism and biosynthesis of chondroitin sulfate.The results of KEGG showed that the up-regulated proteins were mainly enriched in the pathways of proximal tubular bicarbonate recovery,bile secretion,N-glycan biosynthesis,insulin secretion,and aldosterone synthesis and secretion.Down-regulated proteins were mainly enriched in neurodegenerative diseases,such as Alzheimer's disease,Huntington's disease,Parkinson's disease,spinocerebellar ataxia,etc.Conclusion:There are significant differences between bone metastasis and non-bone metastasis histones in lung adenocarcinoma,and the discovery of novel protein markers provides new clues for early screening and diagnosis of bone metastasis.

References:

[1]KANG Y,JIN Y,LI Q,et al.Advances in lung cancer driver genes associated with brain metastasis[J].Frontiers in Oncology,2021,10:606300.
[2]SIEGEL RL,MILLER KD,JEMAL A.Cancer statistics,2020[J].CA:A Cancer Journal for Clinicians,2020,70(1):7-30.
[3]DENISENKO TV,BUDKEVICH IN,ZHIVOTOVSKY B.Cell death-based treatment of lung adenocarcinoma[J].Cell Death & Disease,2018,9(2):117.
[4]董智,赵军,柳晨,等.肺癌骨转移诊疗专家共识(2019版)[J].中国肺癌杂志,2019,22(04):187-207. DONG Z,ZHAO J,LIU C,et al.Expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2019 edition) [J].Chinese Journal of Lung Cancer,2019,22(04):187-207.
[5]XIE S,WU Z,QI Y,et al.The metastasizing mechanisms of lung cancer:Recent advances and therapeutic challenges[J].Biomedicine & Pharmacotherapy,2021,138:111450.
[6]WOOD SL,PERNEMALM M,CROSBIE PA,et al.The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets[J].Cancer treatment reviews,2014,40(4):558-566.
[7]KO J,WINSLOW MM,SAGE J.Mechanisms of small cell lung cancer metastasis[J].EMBO Molecular Medicine,2021,13(1):e13122.
[8]POPPER HH.Progression and metastasis of lung cancer[J].Cancer and Metastasis Reviews,2016,35:75-91.
[9]VICENT S,PERURENA N,GOVINDAN R,et al.Bone metastases in lung cancer.Potential novel approaches to therapy[J].American Journal of Respiratory and Critical Care Medicine,2015,192(7):799-809.
[10]KNAPP BJ,DEVARAKONDA S,GOVINDAN R.Bone metastases in non-small cell lung cancer:A narrative review[J].Journal of Thoracic Disease,2022,14(5):1696.
[11]SONG X,CHENG X,JIN X,et al.EGFL6 promotes bone metastasis of lung adenocarcinoma by increasing cancer cell malignancy and bone resorption[J].Clinical & Experimental Metastasis,2023,40(4):357-371.
[12]MEIER F,BRUNNER AD,FRANK M,et al.diaPASEF:parallel accumulation-serial fragmentation combined with data-independent acquisition[J].Nature Methods,2020,17(12):1229-1236.
[13]GEYER PE,HOLDT LM,TEUPSER D,et al.Revisiting biomarker discovery by plasma proteomics[J].Molecular Systems Biology,2017,13(9):942.
[14]SHI Y,AU JS,THONGPRASERT S,et al.A prospective,molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)[J].Journal of Thoracic Oncology,2014,9(2):154-162.
[15]MIDHA A,DEARDEN S,MCCORMACK R.EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology:a systematic review and global map by ethnicity (mutMapII)[J].American Journal of Cancer Research,2015,5(9):2892.
[16]BROUNS AJWM,HENDRIKS LEL,ROBBESOM-VAN DEN BERGE IJ,et al.Association of RANKL and EGFR gene expression with bone metastases in patients with metastatic non-small cell lung cancer[J].Frontiers in Oncology,2023,13:1145001.
[17]ZHOU JZ,RIQUELME MA,GAO X,et al.Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis[J].Oncogene,2015,34(14):1831-1842.
[18]XU J,LI W,XU S,et al.Effect of dermatan sulphate on a C57-mouse model of pulmonary fibrosis[J].Journal of International Medical Research,2019,47(6):2655-2665.
[19]WANG JY,ZHANG W,ROEHRL MW,et al.An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19[J].Journal of Autoimmunity,2021,120:102644.
[20]CHEN JQ,CONTRERAS RG,WANG R,et al.Sodium/potasium ATPase (Na+,K+-ATPase) and ouabain/related cardiac glycosides:a new paradigm for development of anti-breast cancer drugs[J].Breast Cancer Research and Treatment,2006,96(1):1.
[21]SUMIYOSHI S,SHIOZAKI A,KOSUGA T,et al.Functional analysis and clinical importance of ATP1A1 in colon cancer[J].Annals of Surgical Oncology,2023,30(11):6898-6910.
[22]NAKAMURA K,SHIOZAKI A,KOSUGA T,et al.The expression of the alpha1 subunit of Na+/K+-ATPase is related to tumor development and clinical outcomes in gastric cancer[J].Gastric Cancer,2021,24:1278-1292.
[23]MIJATOVIC T,ROLAND I,VAN QUAQUEBEKE E,et al.The α1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers[J].The Journal of Pathology,2007,212(2):170-179.
[24]YANG P,YANG Y,SUN P,et al.βII spectrin (SPTBN1):biological function and clinical potential in cancer and other diseases[J].International Journal of Biological Sciences,2021,17(1):32.
[25]LORENZO DN,EDWARDS RJ,SLAVUTSKY AL.Spectrins:molecular organizers and targets of neurological disorders[J].Nature Reviews Neuroscience,2023,24(4):195-212.
[26]SHEN C,YU Y,LI H,et al.Global profiling of proteolytically modified proteins in human metastatic hepatocellular carcinoma cell lines reveals CAPN 2 centered network[J].Proteomics,2012,12(12):1917-1927.
[27]GU F,ZHANG Y,LIU Y,et al.Lung adenocarcinoma harboring concomitant SPTBN1-ALK fusion,c-Met overexpression,and HER-2 amplification with inherent resistance to crizotinib,chemotherapy,and radiotherapy[J].Journal of Hematology & Oncology,2016,9:1-3.

Memo

Memo:
河北省医学科学研究课题计划(编号:20240476)
Last Update: 1900-01-01